Transconc Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transconc type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transconc Type Today - Breaking & Trending Today

Ascendis Pharma A/S (NASDAQ:ASND) Reaches New 52-Week High at $156.84

Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $156.84 and last traded at $155.12, with a volume of 37003 shares. The stock had previously closed at $156.39. Analysts Set New Price Targets Several equities research analysts […] ....

Ascendis Pharma , Eversource Wealth Advisors , Coppell Advisory Solutions , Quadrant Capital Group , Wells Fargo Company , Cantor Fitzgerald , Us Bancorp , Jefferies Financial Group , Get Free Report , Financial Group , Capital Group , Source Wealth Advisors , Transcon Growth Hormone , Transcon Parathyroid Hormone , Transconc Type , Ascendis Pharmaa S , Nasdaq Asnd ,

Ascendis Pharma A/S (NASDAQ:ASND) Sets New 12-Month High at $156.84

Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday . The company traded as high as $156.84 and last traded at $155.12, with a volume of 37003 shares traded. The stock had previously closed at $156.39. Analyst Upgrades and Downgrades A number of research firms […] ....

Ascendis Pharma , Envestnet Asset Management Inc , Ascendis Pharmaas Company Profile , Affinity Asset Advisors , Wells Fargo Company , Morgan Stanley , Cantor Fitzgerald , Rice Hall James Associates , Blackrock Inc , Jefferies Financial Group , York Mellon Corp , Get Free Report , Financial Group , Asset Management , Hall James , New York Mellon Corp , Transcon Growth Hormone , Transcon Parathyroid Hormone , Transconc Type , Ascendis Pharmaa S , Nasdaq Asnd ,

Artisan Partners Limited Partnership Reduces Holdings in Ascendis Pharma A/S (NASDAQ:ASND)

Artisan Partners Limited Partnership lowered its position in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 3.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,995,408 shares of the biotechnology company’s stock after selling 227,043 shares during the period. […] ....

Ascendis Pharma , Wells Fargo Company , Artisan Partners Limited Partnership , Ascendis Pharmaas Company Profile , Morgan Stanley , Skyview Investment Advisors , Coppell Advisory Solutions , Exchange Commission , Free Report , Partners Limited Partnership , Advisory Solutions , View Investment Advisors , Get Free Report , Transcon Growth Hormone , Transcon Parathyroid Hormone , Transconc Type , Ascendis Pharmaa S , Nasdaq Asnd , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Ascendis Pharma A/S (NASDAQ:ASND) Sets New 52-Week High at $141.81

Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report)’s stock price reached a new 52-week high during trading on Thursday . The company traded as high as $141.81 and last traded at $141.63, with a volume of 617323 shares trading hands. The stock had previously closed at $129.93. Analysts Set New Price Targets Several analysts have […] ....

Ascendis Pharma , Blackrock Inc , Wells Fargo Company , Envestnet Asset Management Inc , Affinity Asset Advisors , Rice Hall James Associates , Ascendis Pharmaas Company Profile , York Mellon Corp , Morgan Stanley , Cantor Fitzgerald , Get Free Report , Asset Management , Hall James , New York Mellon Corp , Transcon Growth Hormone , Transcon Parathyroid Hormone , Transconc Type , Ascendis Pharmaa S , Nasdaq Asnd ,

Ascendis Pharma A/S (NASDAQ:ASND) Receives $145.38 Consensus PT from Brokerages

Shares of Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten research firms that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 […] ....

New Zealand General , New Zealand , Ascendis Pharma , Ascendis Pharmaas Company Profile , Morgan Stanley , Wellington Management Group , Jefferies Financial Group , Wells Fargo Company , Cantor Fitzgerald , Capital International Investors , Westfield Capital Management Co , T Rowe Price Investment Management Inc , Get Free Report , Financial Group , Management Group , Capital Management , Rowe Price Investment Management , International Investors , Get Free , Transcon Growth Hormone , Transcon Parathyroid Hormone , Transconc Type , Ascendis Pharmaa S , Nasdaq Asnd ,